169 related articles for article (PubMed ID: 27661116)
1. Targeting Notch signaling as a novel therapy for retinoblastoma.
Asnaghi L; Tripathy A; Yang Q; Kaur H; Hanaford A; Yu W; Eberhart CG
Oncotarget; 2016 Oct; 7(43):70028-70044. PubMed ID: 27661116
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of the Jagged/Notch pathway inhibits retinoblastoma cell proliferation via suppressing the PI3K/Akt, Src, p38MAPK and Wnt/β‑catenin signaling pathways.
Xiao W; Chen X; He M
Mol Med Rep; 2014 Jul; 10(1):453-8. PubMed ID: 24805975
[TBL] [Abstract][Full Text] [Related]
3. Gamma-secretase inhibitor prevents Notch3 activation and reduces proliferation in human lung cancers.
Konishi J; Kawaguchi KS; Vo H; Haruki N; Gonzalez A; Carbone DP; Dang TP
Cancer Res; 2007 Sep; 67(17):8051-7. PubMed ID: 17804716
[TBL] [Abstract][Full Text] [Related]
4. Notch signaling promotes growth and invasion in uveal melanoma.
Asnaghi L; Ebrahimi KB; Schreck KC; Bar EE; Coonfield ML; Bell WR; Handa J; Merbs SL; Harbour JW; Eberhart CG
Clin Cancer Res; 2012 Feb; 18(3):654-65. PubMed ID: 22228632
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of gamma-secretase activity impedes uterine serous carcinoma growth in a human xenograft model.
Groeneweg JW; Hall TR; Zhang L; Kim M; Byron VF; Tambouret R; Sathayanrayanan S; Foster R; Rueda BR; Growdon WB
Gynecol Oncol; 2014 Jun; 133(3):607-15. PubMed ID: 24667249
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia inhibits growth, proliferation, and increases response to chemotherapy in retinoblastoma cells.
Yang Q; Tripathy A; Yu W; Eberhart CG; Asnaghi L
Exp Eye Res; 2017 Sep; 162():48-61. PubMed ID: 28689747
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of NOTCH signaling by gamma secretase inhibitor engages the RB pathway and elicits cell cycle exit in T-cell acute lymphoblastic leukemia cells.
Rao SS; O'Neil J; Liberator CD; Hardwick JS; Dai X; Zhang T; Tyminski E; Yuan J; Kohl NE; Richon VM; Van der Ploeg LH; Carroll PM; Draetta GF; Look AT; Strack PR; Winter CG
Cancer Res; 2009 Apr; 69(7):3060-8. PubMed ID: 19318552
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of gamma-secretase affects proliferation of leukemia and hepatoma cell lines through Notch signaling.
Suwanjunee S; Wongchana W; Palaga T
Anticancer Drugs; 2008 Jun; 19(5):477-86. PubMed ID: 18418214
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of Notch pathway by a gamma-secretase inhibitor attenuates AKT/mammalian target of rapamycin signaling and glucose uptake in an ERBB2 transgenic breast cancer model.
Efferson CL; Winkelmann CT; Ware C; Sullivan T; Giampaoli S; Tammam J; Patel S; Mesiti G; Reilly JF; Gibson RE; Buser C; Yeatman T; Coppola D; Winter C; Clark EA; Draetta GF; Strack PR; Majumder PK
Cancer Res; 2010 Mar; 70(6):2476-84. PubMed ID: 20197467
[TBL] [Abstract][Full Text] [Related]
10. Notch signaling activation in pediatric low-grade astrocytoma.
Brandt WD; Schreck KC; Bar EE; Taylor I; Marchionni L; Raabe E; Eberhart CG; Rodriguez FJ
J Neuropathol Exp Neurol; 2015 Feb; 74(2):121-31. PubMed ID: 25575134
[TBL] [Abstract][Full Text] [Related]
11. MAML1 regulates cell viability via the NF-κB pathway in cervical cancer cell lines.
Kuncharin Y; Sangphech N; Kueanjinda P; Bhattarakosol P; Palaga T
Exp Cell Res; 2011 Aug; 317(13):1830-40. PubMed ID: 21640102
[TBL] [Abstract][Full Text] [Related]
12. Rapamycin, a mTOR inhibitor, induced growth inhibition in retinoblastoma Y79 cell via down-regulation of Bmi-1.
Wang YD; Su YJ; Li JY; Yao XC; Liang GJ
Int J Clin Exp Pathol; 2015; 8(5):5182-8. PubMed ID: 26191215
[TBL] [Abstract][Full Text] [Related]
13. Antagonists of growth hormone-releasing hormone receptor induce apoptosis specifically in retinoblastoma cells.
Chu WK; Law KS; Chan SO; Yam JC; Chen LJ; Zhang H; Cheung HS; Block NL; Schally AV; Pang CP
Proc Natl Acad Sci U S A; 2016 Dec; 113(50):14396-14401. PubMed ID: 27911838
[TBL] [Abstract][Full Text] [Related]
14. Apoptosis in T cell acute lymphoblastic leukemia cells after cell cycle arrest induced by pharmacological inhibition of notch signaling.
Lewis HD; Leveridge M; Strack PR; Haldon CD; O'neil J; Kim H; Madin A; Hannam JC; Look AT; Kohl N; Draetta G; Harrison T; Kerby JA; Shearman MS; Beher D
Chem Biol; 2007 Feb; 14(2):209-19. PubMed ID: 17317574
[TBL] [Abstract][Full Text] [Related]
15. Pioglitazone inhibits growth of human retinoblastoma cells via regulation of NF-κB inflammation signals.
Wang F; Liu Y; Bi Z
J Recept Signal Transduct Res; 2017 Feb; 37(1):94-99. PubMed ID: 27133446
[TBL] [Abstract][Full Text] [Related]
16. Characterization of etoposide- and cisplatin-chemoresistant retinoblastoma cell lines.
Busch M; Papior D; Stephan H; Dünker N
Oncol Rep; 2018 Jan; 39(1):160-172. PubMed ID: 29192327
[TBL] [Abstract][Full Text] [Related]
17. Antitumoral action of the neurokinin-1-receptor antagonist L-733,060 and mitogenic action of substance P on human retinoblastoma cell lines.
Muñoz M; Rosso M; Pérez A; Coveñas R; Rosso R; Zamarriego C; Soult JA; Montero I
Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2567-70. PubMed ID: 15980249
[TBL] [Abstract][Full Text] [Related]
18. Notch signaling contributes to lung cancer clonogenic capacity in vitro but may be circumvented in tumorigenesis in vivo.
Osanyingbemi-Obidi J; Dobromilskaya I; Illei PB; Hann CL; Rudin CM
Mol Cancer Res; 2011 Dec; 9(12):1746-54. PubMed ID: 21994468
[TBL] [Abstract][Full Text] [Related]
19. Novel quinic acid derivative KZ-41 prevents retinal endothelial cell apoptosis without inhibiting retinoblastoma cell death through p38 signaling.
Zhang Q; Jiang Y; Toutounchian J; Wilson MW; Morales-Tirado V; Miller DD; Yates CR; Steinle JJ
Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):5937-43. PubMed ID: 23942968
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of Nodal inhibits metastatic progression in retinoblastoma.
Asnaghi L; White DT; Yoon L; Price A; Lee GY; Sahoo A; Mumm JS; Eberhart CG
Acta Neuropathol Commun; 2019 Aug; 7(1):137. PubMed ID: 31451106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
